MedicarePartD.guide

A non-government resource built from CMS public data

Maintenance inhalers for COPD and asthma on every 2026 Oklahoma Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in Oklahoma cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

11 plans, cheapest premium first. Scroll sideways for all of them →

Maintenance inhalers for COPD and asthma by 2026 Oklahoma Part D plan
DrugBlue Cross MedicareRx Basic$0.00/moS5715-015Humana Basic Rx Plan$0.00/moS5884-144Wellcare Value Script$5.60/moS4802-156Wellcare Classic$5.70/moS4802-014Humana Value Rx Plan$33.70/moS5884-202HealthSpring Extra Rx$65.40/moS5617-373AARP Medicare Rx Saver from UHC$82.40/moS5921-368Humana Premier Rx Plan$108.60/moS5884-169AARP Medicare Rx Preferred from UHC$121.00/moS5921-404HealthSpring Assurance Rx$126.50/moS5617-113Blue Cross MedicareRx Value$167.30/moS5715-010
Trelegy Elliptafluticasone/umeclidinium/vilanterolTier 316%QL 60/30dTier 325%QL 60/30dTier 325%QL 60/30dTier 325%QL 60/30dTier 320%QL 60/30dTier 317%QL 60/30dTier 317%QL 60/30dTier 3$45.00QL 60/30dTier 316%QL 60/30dTier 320%QL 60/30dTier 318%QL 60/30d
Breztri Aerospherebudesonide/glycopyrrolate/formoterolTier 316%QL 10.7/30dTier 325%QL 10.7/30dTier 325%QL 10.7/30dTier 325%QL 10.7/30dTier 320%QL 10.7/30dNot coveredNot coveredTier 3$45.00QL 10.7/30dTier 316%QL 10.7/30dNot coveredTier 318%QL 10.7/30d
Anoro Elliptaumeclidinium/vilanterolTier 316%QL 60/30dNot coveredTier 325%QL 60/30dTier 325%QL 60/30dNot coveredTier 317%QL 60/30dTier 317%QL 60/30dNot coveredTier 316%QL 60/30dTier 320%QL 60/30dTier 318%QL 60/30d
Stiolto Respimattiotropium/olodaterolTier 316%QL 4/30dTier 325%QL 4/28dNot coveredNot coveredTier 320%QL 4/28dNot coveredTier 317%QL 4/30dTier 3$45.00QL 4/28dTier 316%QL 4/30dNot coveredTier 318%QL 4/30d
SpirivatiotropiumTier 316%QL 4/30dTier 325%QL 30/30dTier 440%QL 4/30dTier 426%QL 4/30dTier 320%QL 30/30dTier 4ST30%QL 4/30dTier 317%QL 30/30dTier 3$45.00QL 30/30dTier 316%QL 30/30dTier 4ST29%QL 4/30dTier 318%QL 4/30d
Incruse ElliptaumeclidiniumTier 316%QL 30/30dNot coveredTier 325%QL 30/30dTier 325%QL 30/30dNot coveredTier 317%QL 30/30dNot coveredNot coveredTier 316%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30d
Breo Elliptafluticasone/vilanterolTier 316%QL 60/30dTier 325%QL 60/30dTier 325%QL 60/30dTier 325%QL 60/30dTier 320%QL 60/30dTier 317%QL 60/30dTier 317%QL 60/30dTier 3$45.00QL 60/30dTier 316%QL 60/30dTier 320%QL 60/30dTier 318%QL 60/30d
Symbicortbudesonide/formoterolNot coveredTier 325%QL 30.6/30dNot coveredNot coveredTier 320%QL 30.6/30dNot coveredTier 317%QL 10.2/30dTier 3$45.00QL 30.6/30dTier 316%QL 10.2/30dNot coveredNot covered
budesonide-formoterolgeneric SymbicortTier 440%QL 30.9/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 432%QL 30.9/30d
Advairfluticasone/salmeterolTier 316%QL 12/30dNot coveredTier 325%QL 12/30dTier 325%QL 12/30dNot coveredTier 317%QL 12/30dNot coveredNot coveredNot coveredTier 320%QL 12/30dTier 318%QL 12/30d
Wixela Inhubfluticasone/salmeterol, generic AdvairTier 316%QL 60/30dNot coveredNot coveredNot coveredNot coveredNot coveredTier 317%QL 60/30dNot coveredTier 316%QL 60/30dNot coveredTier 318%QL 60/30d
Duleramometasone/formoterolTier 316%QL 39/30dNot coveredNot coveredNot coveredNot coveredNot coveredTier 441%QL 13/30dNot coveredTier 440%QL 13/30dNot coveredTier 318%QL 39/30d
Arnuity Elliptafluticasone furoateTier 316%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 317%QL 30/30dNot coveredTier 3$45.00QL 30/30dTier 316%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.